Groups

Research Focus

Medicine; Assistant Attending L1

Recent additions – View all

1. Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL

   Journal Article

   Culbert, A. A.; Gava, F.; Valtis, Y. K.; Satta, T.; Vora, S.; Rocco, J. M.; Nussenblatt, V.; Silbert, S. K.; Shalabi, H.; Yates, B.; more...
   Journal for ImmunoTherapy of Cancer (2025)

   Fulltext@MSK | Save
2. Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD

   Meeting Abstract

   Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
   Blood (2023)

   Fulltext@MSK | Save
3. Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax

   Journal Article

   Satta, T.; Li, L.; Chalasani, S. L.; Hu, X.; Nkwocha, J.; Sharma, K.; Kmieciak, M.; Rahmani, M.; Zhou, L.; Grant, S.
   Clinical Cancer Research (2023)

   Fulltext@MSK | Save